As of 2025-07-09, the EV/EBITDA ratio of Boill Healthcare Holdings Ltd (1246.HK) is -3.50. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. 1246.HK's latest enterprise value is 870.22 mil HKD. 1246.HK's TTM EBITDA according to its financial statements is -248.83 mil HKD. Dividing these 2 quantities gives us the above 1246.HK EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
Range | Selected | |
Trailing P/E multiples | 7.3x - 16.8x | 13.3x |
Forward P/E multiples | 4.4x - 7.4x | 5.0x |
Fair Price | (1.96) - (1.98) | (2.30) |
Upside | -9421.0% - -9508.3% | -11035.2% |
Date | EV/EBITDA |
2025-07-08 | -3.50 |
2025-07-07 | -3.50 |
2025-07-04 | -3.50 |
2025-07-03 | -3.50 |
2025-07-02 | -3.50 |
2025-06-30 | -3.50 |
2025-06-27 | -3.50 |
2025-06-26 | -3.50 |
2025-06-25 | -3.50 |
2025-06-24 | -3.50 |
2025-06-23 | -3.50 |
2025-06-20 | -3.50 |
2025-06-19 | -3.50 |
2025-06-18 | -3.50 |
2025-06-17 | -3.50 |
2025-06-16 | -3.50 |
2025-06-13 | -3.50 |
2025-06-12 | -3.50 |
2025-06-11 | -3.50 |
2025-06-10 | -3.50 |
2025-06-09 | -3.50 |
2025-06-06 | -3.50 |
2025-06-05 | -3.50 |
2025-06-04 | -3.50 |
2025-06-03 | -3.50 |
2025-06-02 | -3.50 |
2025-05-30 | -3.50 |
2025-05-29 | -3.50 |
2025-05-28 | -3.50 |
2025-05-27 | -3.50 |
2025-05-26 | -3.50 |
2025-05-23 | -3.50 |
2025-05-22 | -3.50 |
2025-05-21 | -3.50 |
2025-05-20 | -3.50 |
2025-05-19 | -3.50 |
2025-05-16 | -3.50 |
2025-05-15 | -3.50 |
2025-05-14 | -3.50 |
2025-05-13 | -3.50 |
2025-05-12 | -3.50 |
2025-05-09 | -3.50 |
2025-05-08 | -3.50 |
2025-05-07 | -3.50 |
2025-05-06 | -3.50 |
2025-05-02 | -3.50 |
2025-04-30 | -3.50 |
2025-04-29 | -3.50 |
2025-04-28 | -3.50 |
2025-04-25 | -3.50 |